Asset Details
Do you wish to reserve the book?
Aberrant alternative splicing in cancer: Splicing events and their regulatory mechanisms (Review)
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Aberrant alternative splicing in cancer: Splicing events and their regulatory mechanisms (Review)
Do you wish to request the book?
Aberrant alternative splicing in cancer: Splicing events and their regulatory mechanisms (Review)
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Aberrant alternative splicing in cancer: Splicing events and their regulatory mechanisms (Review)
2024
Overview
Alternative RNA splicing provides cells with transcriptomic and proteomic diversity by adding another layer of regulation to gene expression. Accumulating evidence has revealed that defects in alternative splicing contribute to a variety of features of cancer development, including the modulation of cancer heterogeneity, evasion of apoptosis of cancer cells, rewiring cancer metabolism and facilitating cancer metastasis via fine-tuning the epithelial-to-mesenchymal transition process. In this review, well-known aberrant alternative splicing events associated with multiple aspects of cancer progression were presented based on available data obtained from an extensive literature search used to construct splicing regulatory networks for each of these events. The study aims to provide a more comprehensive understanding of cancer-associated splicing networks and more precise guidance for targeting these events for cancer treatment.
